Literature DB >> 25503737

Post Mortem Human Surrogate Injury Response of the Pelvis and Lower Extremities to Simulated Underbody Blast.

Ann M Bailey1, John J Christopher, Frederick Brozoski, Robert S Salzar.   

Abstract

Military vehicle underbody blast (UBB) is the cause of many serious injuries in theatre today; however, the effects of these chaotic events on the human body are not well understood. The purpose of this research was to replicate both UBB loading conditions and investigate occupant response in a controlled laboratory setting. In addition to better understanding the response of the human to high rate vertical loading, this test series also aimed to identify high rate injury thresholds. Ten whole body post mortem human surrogate (PMHS) tests were completed using the University of Virginia's ODYSSEY simulated blast rig under a range of loading conditions. Seat pan accelerations ranged from 291 to 738 g's over 3 ms of positive phase duration, and foot pan accelerations from 234 to 858 g's over 3 ms of positive phase duration. Post-test computed tomography (CT) scans and necropsies were performed to determine injuries, and revealed a combination of pelvic, lumbar, thoracic, and lower extremity injuries. The research in this paper discusses pelvis and lower extremity injuries under high rate vertical loads.

Entities:  

Mesh:

Year:  2014        PMID: 25503737     DOI: 10.1007/s10439-014-1211-5

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  2 in total

1.  Severe Calcaneus Injury Probability Curves Due to Under-Body Blast.

Authors:  Liming Voo; Kyle Ott; Thomas Metzger; Andrew Merkle; David Drewry
Journal:  Ann Biomed Eng       Date:  2021-06-11       Impact factor: 3.934

2.  Experimental Study of Thoracoabdominal Injuries Suffered from Caudocephalad Impacts Using Pigs.

Authors:  Sishu Guan; Zhikang Liao; Hongyi Xiang; Xiyan Zhu; Zhong Wang; Hui Zhao; Peng Liu; Xinan Lai
Journal:  Appl Bionics Biomech       Date:  2018-05-10       Impact factor: 1.781

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.